CGEMCullinan Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Cullinan Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CGEMThis | $1.3B#6 | — | 3.2x#7 | — | -100.0%#9 | -31.2%#8 | — | -53.8%#8 | — | — | 224.1%#2 | — |
| VIR | $1.8B#1 | — | 1.8x#1 | 25.8x#5 | -7.6%#7 | 16.1%#4 | -699.2%#4 | -44.6%#6 | — | — | 117.7%#5 | — |
| RXRX | $1.7B#2 | — | 1.9x#2 | 23.2x#4 | 26.9%#4 | -39.1%#9 | -867.9%#5 | -70.5%#9 | -175.2%#2 | — | -32.3%#13 | — |
| TSHA | $1.7B#3 | — | 4.3x#8 | 169.0x#7 | 17.3%#5 | -22.1%#6 | -1130.6%#6 | -28.1%#3 | — | — | 68.2%#8 | — |
| INBX | $1.6B#4 | — | — | 1205.0x#8 | 550.0%#1 | -108.3%#11 | -10386.5%#8 | — | — | — | 292.0%#1 | — |
| MAZE | $1.3B#5 | — | 3.0x#6 | 8.0x#1 | — | -351.0%#12 | -85.3%#2 | -28.9%#4 | -49.4%#1 | — | 4.2%#10 | — |
| VOR | $1.3B#7 | 0.1x#1 | — | — | — | -495.3%#13 | — | — | — | — | -29.8%#12 | — |
| MGTX | $1.2B#9 | 14.7x#2 | — | 15.1x#3 | 144.6%#2 | 22.7%#3 | -130.2%#3 | — | — | — | 74.1%#7 | — |
| GLUE | $1.1B#10 | — | 2.3x#3 | 9.0x#2 | 63.5%#3 | 46.9%#1 | -43.8%#1 | -7.9%#2 | — | — | 87.8%#6 | — |
| REPL | $1.2B#8 | — | 11.6x#11 | — | — | -26.9%#7 | — | -297.1%#11 | -7270.9%#3 | — | 130.1%#3 | — |
| ODTX | $1.1B#11 | — | 2.5x#5 | — | — | — | — | 0.0%#1 | — | — | — | — |
| SANA | $949M#12 | — | 6.1x#9 | — | — | 8.5%#5 | — | -158.0%#10 | — | — | -1.9%#11 | — |
| SLDB | $896M#13 | — | 2.4x#4 | 110.7x#6 | -40.6%#8 | -39.8%#10 | -2214.1%#7 | -46.6%#7 | — | — | 52.1%#9 | — |
| CADL | $852M#14 | — | 6.8x#10 | 6813.2x#9 | 0.0%#6 | 30.8%#2 | -38612.8%#9 | -30.3%#5 | — | — | 129.7%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice